ArticleAnnals of the rheumatic diseases2021

Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases.

Caoilfhionn M Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.